Cushing's syndrome – Disease monitoring: Recurrence, surveillance with biomarkers or imaging studies

Pivonello, 2015, The treatment of cushing's disease, Endocr Rev, 36, 385, 10.1210/er.2013-1048 Nieman, 2015, Treatment of cushing's syndrome: an endocrine society clinical practice guideline, J Clin Endocrinol Metab, 100, 2807, 10.1210/jc.2015-1818 Lacroix, 2015, Cushing's syndrome, Lancet, 386, 913, 10.1016/S0140-6736(14)61375-1 Castinetti, 2019, Radiotherapy as a tool for the treatment of Cushing's disease, Eur J Endocrinol, 180, D9, 10.1530/EJE-19-0092 Assie, 2007, Corticotroph tumor progression after adrenalectomy in Cushing's Disease: a reappraisal of Nelson's Syndrome, J Clin Endocrinol Metab, 92, 172, 10.1210/jc.2006-1328 Guerin, 2016, Bilateral adrenalectomy in the 21st century: when to use it for hypercortisolism?, Endocr Relat Canc, 23, R131, 10.1530/ERC-15-0541 Broersen, 2018, Effectiveness of medical treatment for Cushing's syndrome: a systematic review and meta-analysis, Pituitary, 21, 631, 10.1007/s11102-018-0897-z Lindholm, 2001, Incidence and late prognosis of cushing's syndrome: a population-based study, J Clin Endocrinol Metab, 86, 117 Wengander, 2019, The incidence of endogenous Cushing's syndrome in the modern era, Clin Endocrinol, 91, 263, 10.1111/cen.14014 Osswald, 2019, Long-term outcome of primary bilateral macronodular adrenocortical hyperplasia after unilateral adrenalectomy, J Clin Endocrinol Metab, 104, 2985, 10.1210/jc.2018-02204 Osswald, 2014, Favorable long-term outcomes of bilateral adrenalectomy in Cushing's disease, Eur J Endocrinol, 171, 209, 10.1530/EJE-14-0214 Xu, 2013, The role of unilateral adrenalectomy in corticotropin-independent bilateral adrenocortical hyperplasias, World J Surg, 37, 1626, 10.1007/s00268-013-2059-9 Albiger, 2019, Different therapeutic options in patients with Cushing's syndrome due to bilateral macronodular adrenal hyperplasia, Minerva Endocrinol, 44, 205, 10.23736/S0391-1977.17.02771-7 Ragnarsson, 2019, Overall and disease-specific mortality in patients with cushing disease: a Swedish nationwide study, J Clin Endocrinol Metab, 104, 2375, 10.1210/jc.2018-02524 Clayton, 2016, Mortality in patients with Cushing's disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study, Lancet Diabetes Endocrinol, 4, 569, 10.1016/S2213-8587(16)30005-5 Clayton, 2011, Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature, J Clin Endocrinol Metab, 96, 632, 10.1210/jc.2010-1942 Dekkers, 2007, Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma, J Clin Endocrinol Metab, 92, 976, 10.1210/jc.2006-2112 Pivonello, 2016, Complications of Cushing's syndrome: state of the art, Lancet Diabetes Endocrinol, 4, 611, 10.1016/S2213-8587(16)00086-3 Dekkers, 2013, Multisystem morbidity and mortality in Cushing's syndrome: a cohort study, J Clin Endocrinol Metab, 98, 2277, 10.1210/jc.2012-3582 Ragnarsson, 2013, Cushing's syndrome: a structured short- and long-term management plan for patients in remission, Eur J Endocrinol, 169, R139, 10.1530/EJE-13-0534 Jagannathan, 2009, Outcome of using the histological pseudocapsule as a surgical capsule in Cushing disease, J Neurosurg, 111, 531 Sonino, 1996, Risk factors and long-term outcome in pituitary-dependent Cushing's disease, J Clin Endocrinol Metab, 81, 2647 Broersen, 2019, Microscopic versus endoscopic transsphenoidal surgery in the Leiden cohort treated for Cushing's disease: surgical outcome, mortality, and complications, Orphanet J Rare Dis, 14, 64, 10.1186/s13023-019-1038-0 Feng, 2018, Diagnosis and outcomes of 341 patients with cushing's disease following transsphenoid surgery: a single-center experience, World Neurosurg, 109, e75, 10.1016/j.wneu.2017.09.105 Petersenn, 2015, Therapy of endocrine disease: outcomes in patients with Cushing's disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence, Eur J Endocrinol, 172, R227, 10.1530/EJE-14-0883 Broersen, 2018, Endoscopic vs. microscopic transsphenoidal surgery for Cushing's disease: a systematic review and meta-analysis, Pituitary, 21, 524, 10.1007/s11102-018-0893-3 Hammer, 2004, Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results, J Clin Endocrinol Metab, 89, 6348, 10.1210/jc.2003-032180 Hofmann, 2008, Long-term results after microsurgery for Cushing disease: experience with 426 primary operations over 35 years, J Neurosurg, 108, 9 Patil, 2008, Late recurrences of Cushing's disease after initial successful transsphenoidal surgery, J Clin Endocrinol Metab, 93, 358, 10.1210/jc.2007-2013 Valassi, 2010, Delayed remission after transsphenoidal surgery in patients with Cushing's disease, J Clin Endocrinol Metab, 95, 601, 10.1210/jc.2009-1672 Lambert, 2013, Predictors of mortality and long-term outcomes in treated Cushing's disease: a study of 346 patients, J Clin Endocrinol Metab, 98, 1022, 10.1210/jc.2012-2893 Chandler, 2016, Outcome of transsphenoidal surgery for cushing disease: a single-center experience over 32 years, Neurosurgery, 78, 216, 10.1227/NEU.0000000000001011 Cebula, 2017, Efficacy of endoscopic endonasal transsphenoidal surgery for Cushing's disease in 230 patients with positive and negative MRI, Acta Neurochir, 159, 1227, 10.1007/s00701-017-3140-1 Ironside, 2018, Earlier post-operative hypocortisolemia may predict durable remission from Cushing's disease, Eur J Endocrinol, 178, 255, 10.1530/EJE-17-0873 Abu Dabrh, 2016, Predictors of biochemical remission and recurrence after surgical and radiation treatments of cushing disease: a systematic review and meta-analysis, Endocr Pract, 22, 466, 10.4158/EP15922.RA Carroll, 2016, Postsurgical recurrent cushing disease: clinical benefit of early intervention in patients with normal urinary free cortisol, Endocr Pract, 22, 1216, 10.4158/EP161380.OR Danet-Lamasou, 2015, Accuracy of repeated measurements of late-night salivary cortisol to screen for early-stage recurrence of Cushing's disease following pituitary surgery, Clin Endocrinol, 82, 260, 10.1111/cen.12534 Amlashi, 2015, Accuracy of late-night salivary cortisol in evaluating postoperative remission and recurrence in cushing's disease, J Clin Endocrinol Metab, 100, 3770, 10.1210/jc.2015-2107 Storr, 2011, Comparisons in the epidemiology, diagnostic features and cure rate by transsphenoidal surgery between paediatric and adult-onset Cushing's disease, Eur J Endocrinol, 164, 667, 10.1530/EJE-10-1120 Crock, 2018, A personal series of 100 children operated for Cushing's disease (CD): optimizing minimally invasive diagnosis and transnasal surgery to achieve nearly 100% remission including reoperations, J Pediatr Endocrinol Metab, 31, 1023, 10.1515/jpem-2018-0262 Qiao, 2018, Cushing's disease in older patients: presentation and outcome, Clin Endocrinol, 89, 444, 10.1111/cen.13799 Mehta, 2017, Stereotactic radiosurgery for cushing disease: results of an international, multicenter study, J Clin Endocrinol Metab, 102, 4284, 10.1210/jc.2017-01385 Castinetti, 2009, Long-term results of stereotactic radiosurgery in secretory pituitary adenomas, J Clin Endocrinol Metab, 94, 3400, 10.1210/jc.2008-2772 Debillon, 2015, Unilateral adrenalectomy as a first-line treatment of cushing's syndrome in patients with primary bilateral macronodular adrenal hyperplasia, J Clin Endocrinol Metab, 100, 4417, 10.1210/jc.2015-2662 Albiger, 2015, An analysis of different therapeutic options in patients with Cushing's syndrome due to bilateral macronodular adrenal hyperplasia: a single-centre experience, Clin Endocrinol, 82, 808, 10.1111/cen.12763 Kyrilli, 2019, Unilateral adrenalectomy could Be a valid option for primary nodular adrenal disease: evidence from twins, J Endocr Soc, 3, 129, 10.1210/js.2018-00261 Powell, 2008, Operative management of Cushing syndrome secondary to micronodular adrenal hyperplasia, Surgery, 143, 750, 10.1016/j.surg.2008.03.022 Keskin, 2017, Outcomes of primary transsphenoidal surgery in cushing disease: experience of a tertiary center, World Neurosurg, 106, 374, 10.1016/j.wneu.2017.07.014 Johnston, 2017, Surgical outcomes in patients with Cushing's disease: the Cleveland clinic experience, Pituitary, 20, 430, 10.1007/s11102-017-0802-1 Uvelius, 2018, An early post-operative ACTH suppression test can safely predict short- and long-term remission after surgery of Cushing's disease, Pituitary, 21, 490, 10.1007/s11102-018-0902-6 Abellan-Galiana, 2019, Prognostic usefulness of ACTH in the postoperative period of Cushing's disease, Endocr Conn, 8, 1262, 10.1530/EC-19-0297 Bochicchio, 1995, Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group, J Clin Endocrinol Metab, 80, 3114 Alwani, 2010, Biochemical predictors of outcome of pituitary surgery for Cushing's disease, Neuroendocrinology, 91, 169, 10.1159/000258677 Barbot, 2013, Predicting late recurrence in surgically treated patients with Cushing's disease, Clin Endocrinol, 79, 394, 10.1111/cen.12133 Brichard, 2018, Outcome of transsphenoidal surgery for cushing disease: a single-center experience over 20 years, World Neurosurg, 119, e106, 10.1016/j.wneu.2018.07.055 Aranda, 2015, Long-term remission and recurrence rate in a cohort of Cushing's disease: the need for long-term follow-up, Pituitary, 18, 142, 10.1007/s11102-014-0567-8 Lonser, 2013, Outcome of surgical treatment of 200 children with Cushing's disease, J Clin Endocrinol Metab, 98, 892, 10.1210/jc.2012-3604 Dimopoulou, 2014, Long-term remission and recurrence rates after first and second transsphenoidal surgery for Cushing's disease: care reality in the Munich Metropolitan Region, Eur J Endocrinol, 170, 283, 10.1530/EJE-13-0634 Berr, 2015, Time to recovery of adrenal function after curative surgery for Cushing's syndrome depends on etiology, J Clin Endocrinol Metab, 100, 1300, 10.1210/jc.2014-3632 Alexandraki, 2013, Long-term remission and recurrence rates in Cushing's disease: predictive factors in a single-centre study, Eur J Endocrinol, 168, 639, 10.1530/EJE-12-0921 Bansal, 2017, Duration of post-operative hypocortisolism predicts sustained remission after pituitary surgery for Cushing's disease, Endocr Conn, 6, 625, 10.1530/EC-17-0175 Lodish, 2012, Recovery of the hypothalamic-pituitary-adrenal axis in children and adolescents after surgical cure of Cushing's disease, J Clin Endocrinol Metab, 97, 1483, 10.1210/jc.2011-2325 Vassiliadi, 2016, The desmopressin test predicts better than basal cortisol the long-term surgical outcome of cushing's disease, J Clin Endocrinol Metab, 101, 4878, 10.1210/jc.2016-2799 Romanholi, 2008, Role for postoperative cortisol response to desmopressin in predicting the risk for recurrent Cushing's disease, Clin Endocrinol, 69, 117, 10.1111/j.1365-2265.2007.03168.x Le Marc'hadour, 2015, Postoperative follow-up of Cushing's disease using cortisol, desmopressin and coupled dexamethasone-desmopressin tests: a head-to-head comparison, Clin Endocrinol, 83, 216, 10.1111/cen.12739 Losa, 2009, Persistent adrenocorticotropin response to desmopressin in the early postoperative period predicts recurrence of Cushing's disease, J Clin Endocrinol Metab, 94, 3322, 10.1210/jc.2009-0844 Moloney, 2014, Detecting post-surgical recurrence in a patient with Cushing's disease, J Neuro Oncol, 117, 191, 10.1007/s11060-013-1343-8 Giordano, 2011, Metabolic and cardiovascular outcomes in patients with Cushing's syndrome of different aetiologies during active disease and 1 year after remission, Clin Endocrinol, 75, 354, 10.1111/j.1365-2265.2011.04055.x Isidori, 2015, The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications, J Hypertens, 33, 44, 10.1097/HJH.0000000000000415 Nieman, 2008, The diagnosis of cushing's syndrome: an endocrine society clinical practice guideline, J Clin Endocrinol Metab, 93, 1526, 10.1210/jc.2008-0125 Elias, 2014, Late-night salivary cortisol has a better performance than urinary free cortisol in the diagnosis of Cushing's syndrome, J Clin Endocrinol Metab, 99, 2045, 10.1210/jc.2013-4262 Bou Khalil, 2011, Sequential hormonal changes in 21 patients with recurrent Cushing's disease after successful pituitary surgery, Eur J Endocrinol, 165, 729, 10.1530/EJE-11-0424 Sandouk, 2018, Variability of late-night salivary cortisol in cushing disease: a prospective study, J Clin Endocrinol Metab, 103, 983, 10.1210/jc.2017-02020 Vassiliadi, 2018, Diagnosis of endocrine disease: the role of the desmopressin test in the diagnosis and follow-up of Cushing's syndrome, Eur J Endocrinol, 178, R201, 10.1530/EJE-18-0007 Dall'Asta, 2004, Recurrence of Cushing's disease preceded by the reappearance of ACTH and cortisol responses to desmopressin test, Pituitary, 7, 183, 10.1007/s11102-005-0425-9 Ambrosi, 2009, Desmopressin test may predict the risk of recurrence in Cushing's disease, Clin Endocrinol, 70, 811, 10.1111/j.1365-2265.2008.03406.x Ambrogio, 2017, Usefulness of desmopressin testing to predict relapse during long-term follow-up in patients in remission from Cushing's disease, Endocr Conn, 6, 791, 10.1530/EC-17-0292 Fleseriu, 2016, American association of clinical endocrinologists and American college of endocrinology disease state clinical review: diagnosis of recurrence in cushing disease, Endocr Pract, 22, 1436, 10.4158/EP161512.DSCR Eisenhofer, 2018, Plasma steroid metabolome profiling for diagnosis and subtyping patients with cushing syndrome, Clin Chem, 64, 586, 10.1373/clinchem.2017.282582 Puar, 2017, Bilateral testicular tumors resulting in recurrent cushing disease after bilateral adrenalectomy, J Clin Endocrinol Metab, 102, 339, 10.1210/jc.2016-2702 Nelson, 1960, ACTH-producing pituitary tumors following adrenalectomy for Cushing's syndrome, Ann Intern Med, 52, 560, 10.7326/0003-4819-52-3-560 Azad, 2015, Nelson syndrome: update on therapeutic approaches, World Neurosurg, 83, 1135, 10.1016/j.wneu.2015.01.038 Barber, 2010, Nelson's syndrome, Eur J Endocrinol, 163, 495, 10.1530/EJE-10-0466 Graffeo, 2017, Characterizing and predicting the Nelson-Salassa syndrome, J Neurosurg, 127, 1277 Kemink, 1994, Patient's age is a simple predictive factor for the development of Nelson's syndrome after total adrenalectomy for Cushing's disease, J Clin Endocrinol Metab, 79, 887 Nagesser, 2000, Long-term results of total adrenalectomy for Cushing's disease, World J Surg, 24, 108, 10.1007/s002689910020 Ritzel, 2013, Clinical review: outcome of bilateral adrenalectomy in Cushing's syndrome: a systematic review, J Clin Endocrinol Metab, 98, 3939, 10.1210/jc.2013-1470 Kasperlik-Zaluska, 1983, Nelson's syndrome: incidence and prognosis, Clin Endocrinol, 19, 693, 10.1111/j.1365-2265.1983.tb00046.x Jenkins, 1995, The long-term outcome after adrenalectomy and prophylactic pituitary radiotherapy in adrenocorticotropin-dependent Cushing's syndrome, J Clin Endocrinol Metab, 80, 165 Pereira, 1998, A study of patients with Nelson's syndrome, Clin Endocrinol, 49, 533, 10.1046/j.1365-2265.1998.00578.x Gil-Cardenas, 2007, Nelson's syndrome after bilateral adrenalectomy for Cushing's disease, Surgery, 141, 147, 10.1016/j.surg.2006.12.003 Smith, 2009, Bilateral adrenalectomy for refractory Cushing disease: a safe and definitive therapy, J Am Coll Surg, 208, 1059, 10.1016/j.jamcollsurg.2009.02.054 Gil-Cardenas, 2008, Laparoscopic adrenalectomy: lessons learned from an initial series of 100 patients, Surg Endosc, 22, 991, 10.1007/s00464-007-9556-6 van Aken, 2004, Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease, Clin Endocrinol, 60, 765, 10.1111/j.1365-2265.2004.02052.x Kemink, 2001, Management of Nelson's syndrome: observations in fifteen patients, Clin Endocrinol, 54, 45, 10.1046/j.1365-2265.2001.01187.x Geer, 2017, Follow-up intervals in patients with Cushing's disease: recommendations from a panel of experienced pituitary clinicians, Pituitary, 20, 422, 10.1007/s11102-017-0801-2 Banasiak, 2007, Nelson syndrome: comprehensive review of pathophysiology, diagnosis, and management, Neurosurg Focus, 23, E13, 10.3171/foc.2007.23.3.15 Ray, 1995, Elevated levels of adrenocorticotropin (ACTH) precursors in post-adrenalectomy Cushing's disease and their regulation by glucocorticoids, J Clin Endocrinol Metab, 80, 2430